Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04169204
Other study ID # 19-021
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date May 19, 2020
Est. completion date May 30, 2024

Study information

Verified date January 2024
Source Heinrich-Heine University, Duesseldorf
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Shock is a frequent, etiologically heterogeneous and often lethal clinical condition of intensive care medicine. This is particularly true for very old intensive care patients (VIPs), who are among the fastest-growing subgroups of all intensive care unit (ICU) patients and who suffer from a significantly impaired outcome. In addition to the treatment of the causes of shock, current therapeutic approaches focus on the stabilization of vital parameters, which in general all reflect macrocirculatory measured values such as blood pressure. In contrast, a disturbance of the microcirculation (blood circulation of the smaller blood vessels <100 µm) is only poorly measurable and delayed. The last generation of AVA-Software (MicroVisionMedical) will calculate different parameters about the capillary densitiv and perfusion in a user-independent way. VIPPER investigates whether a non-invasive measurement of microcirculation using the sublingual mucosa in very old intensive care patients in shock leads to faster recognition and specific treatment of organ dysfunctions. Secondly, this study checks whether this measurement predicts outcome.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 47
Est. completion date May 30, 2024
Est. primary completion date May 31, 2023
Accepts healthy volunteers No
Gender All
Age group 80 Years and older
Eligibility Inclusion Criteria: - = 80 years - Acute ICU admission - Shock at the time point of admission to the ICU or in the first 3 hours defined as Lactate = 2 mmol/l AND need for vasoactive substances to maintain a MAP = 65 mmHg in the presence of adequate volume status Exclusion Criteria: - < 80 years - Inaccessibility for sublingual measurement - no informed consent

Study Design


Intervention

Diagnostic Test:
Measurement of microcirculation
As a simple clinical test, every patient will receive the assessment capillary refill time and mottling-score. Additionally, repetitive measurements of lactate will be done. The SDF-camera (MicroVision Medical®, Amsterdam, Netherlands) will measure sublingual microcirculation at different time points (Admission and 24h).

Locations

Country Name City State
Germany Division of Cardiology, Pulmonary Disease and Vascular Medicine Duesseldorf

Sponsors (1)

Lead Sponsor Collaborator
Heinrich-Heine University, Duesseldorf

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary bedside measurement of sublingual microcirculation measurement of sublingual microcirculation by using MicroScan® microscope admission of the intensive care unit
Primary bedside measurement of sublingual microcirculation measurement of sublingual microcirculation by using MicroScan® microscope after 24 hours
Secondary Mortality after 30 days, 6 months and 12 months
Secondary Length of stay at ICU tdays from admission of the intensive care unit until discharge
Secondary Use of Vasopressors and fluids days from admission of the intensive care unit until discharge
See also
  Status Clinical Trial Phase
Completed NCT00487097 - The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients N/A
Completed NCT01997931 - The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients N/A
Recruiting NCT04926220 - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting NCT03617796 - Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
Withdrawn NCT04554264 - Complicated Grief in ICU in the Aftermath of COVID-19 N/A
Recruiting NCT02587273 - The Pharmacokinetics of Fentanyl in Intensive Care Patients Phase 4
Withdrawn NCT01749488 - The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A
Completed NCT04186611 - Early Occupational Therapy in Intensive Care: Feasibility of Implementation N/A
Completed NCT03299894 - Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department N/A
Recruiting NCT03777150 - Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients? N/A
Completed NCT02583321 - Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate N/A
Completed NCT00787098 - Investigating Modes of Progressive Mobility Phase 2
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Completed NCT02476591 - Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care N/A
Completed NCT05795777 - Examination of the Pressure Ulcers in Intensive Care Patients.
Terminated NCT02587130 - Ketamine and Refractory Painful Care in a Palliative Unit Phase 4
Completed NCT02463123 - Energy Expenditure Estimation in Cardiac Surgery N/A
Completed NCT01607723 - "NAVA-PAV" Study: a Cross-over Comparative Study of 2 Advanced Modes Phase 3
Completed NCT01346813 - Epidemiology of Painful Procedures in Neonates N/A